Business News

Cohance to further invest USD 18M to strengthen its ADC strategy

FinSiddhi

Cohance Lifesciences today announced two proposed transactions to strengthen its Antibody-drug Conjugate (ADC) strategy: an additional investment of USD 13 million in NJ Bio and a controlling investment of USD 5 million in Aruka Bio. Both the transactions will be funded through internal accruals.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Smriti Irani’s big comeback: Why BJP has turned to its ‘giant killer’

Smriti Irani is reappointed as a general secretary for the BJP’s national team, a move that highlights the party’s strategic push in Uttar Pradesh ahead of upcoming elections. Following setbacks in the recent Lok Sabha elections, her previous success in Amethi positions her as a critical asset. This role will see her coordinating with state…

5 Sneaky reasons taht are not letting you lose weight

Beverages can secretly sabotage your weight loss journey with hidden calories that stack up over time. Overindulging in healthy foods can also stall your progress. Additionally, chronic stress and insufficient sleep can hinder fat loss efforts. Weekend splurges may erase the hard work of your weekdays, while a sedentary lifestyle significantly lowers your calorie burn…